<code id='07CD46AB57'></code><style id='07CD46AB57'></style>
    • <acronym id='07CD46AB57'></acronym>
      <center id='07CD46AB57'><center id='07CD46AB57'><tfoot id='07CD46AB57'></tfoot></center><abbr id='07CD46AB57'><dir id='07CD46AB57'><tfoot id='07CD46AB57'></tfoot><noframes id='07CD46AB57'>

    • <optgroup id='07CD46AB57'><strike id='07CD46AB57'><sup id='07CD46AB57'></sup></strike><code id='07CD46AB57'></code></optgroup>
        1. <b id='07CD46AB57'><label id='07CD46AB57'><select id='07CD46AB57'><dt id='07CD46AB57'><span id='07CD46AB57'></span></dt></select></label></b><u id='07CD46AB57'></u>
          <i id='07CD46AB57'><strike id='07CD46AB57'><tt id='07CD46AB57'><pre id='07CD46AB57'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:5187
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Harvard's David Sinclair gets blowback over aging
          Harvard's David Sinclair gets blowback over aging

          DavidSinclairinhislabatHarvardMedicalSchool.CraigF.Walker/GlobeStaffRenownedHarvardUniversitygenetic

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          Boston Scientific acquires urology company Axonics for $3.7 billion

          BostonScientificisgrowingitsurologyportfoliowiththeAxonicsacquisition.StevenSenne/APBostonScientific